LEONE D PATTERSON Insider Trading $DDXS Diadexus, Inc.
Get free email notifications about insider trading for LEONE D PATTERSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LEONE D PATTERSON. LEONE D PATTERSON is Vice President, Controller in CHIRON CORP ($CHIR) and Vice President; Controller in CHIRON CORP ($CHIR) and Chief Financial Officer in Diadexus, Inc. ($DDXS) and CEO, CFO and Director in Adverum Biotechnologies, Inc. ($ADVM) and CEO, President and Director in Adverum Biotechnologies, Inc. ($ADVM) and CFO in Adverum Biotechnologies, Inc. ($AAVL) and Chief Financial Officer in Adverum Biotechnologies, Inc. ($ADVM) and President in Adverum Biotechnologies, Inc. ($ADVM) and President and CFO in Adverum Biotechnologies, Inc. ($ADVM) and President, CEO and CFO in Adverum Biotechnologies, Inc. ($ADVM) and SVP, CFO, Interim Pres and CEO in Adverum Biotechnologies, Inc. ($ADVM) and Director in Nkarta, Inc. ($NKTX).
LEONE D PATTERSON in Diadexus, Inc.
Trading Symbol: DDXSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LEONE D PATTERSON: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Mar 24 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LEONE D PATTERSON in Diadexus, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, CHIR, DDXS, NKTX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 24 2015 | DDXS | Diadexus, Inc. | PATTERSON LEONE D | Chief Financial Off ... | Option Exercise | A | 0.37 | 700,000 | 259,000 | 700,000 |
Page: 1